
According to data from Benzinga Pro, during Q4, OptiNose's (NASDAQ:OPTN) reported sales totaled $22.51 million. Despite a 8.72% increase in earnings, the company posted a loss of $15.62 million. OptiNose collected $21.83 million in revenue during Q3, but reported earnings showed a $17.12 million loss.